Efficacy and safety of mesenchymal stem cell injections for patients with osteoarthritis: a meta-analysis and review of RCTs
- PMID: 33507375
- DOI: 10.1007/s00402-020-03703-0
Efficacy and safety of mesenchymal stem cell injections for patients with osteoarthritis: a meta-analysis and review of RCTs
Abstract
Introduction: Osteoarthritis (OA), which has a high incidence in the elderly, brings a huge economic burden to society. MSCs (Mesenchymal Stem Cells) have shown great multidirectional differentiation potential which are expected to treat OA, and numerous clinical trials have been conducted. However, the efficacy and safety of the MSCs still need to be further integrated and analyzed.
Materials and methods: We searched several databases (PubMed, EMBASE, Scopus, Web of Science, Cochrane Library, Ovid, and ScienceDirect) for assessing eligible trials that randomized controlled trials, hyaluronic acid as control, and MSCs injection to treat OA. Vitro studies and animal studies were excluded. Search terms were: "cartilage," "clinical trial," "mesenchymal," "stromal" and "stem cell", "osteoarthritis". The preliminary guidelines and study protocol were published online at PROSPERO.
Results: Many assessment scales could not be improved significantly after 6 months. However, most of the scales were significantly improved after 12 months, indicating that compared with hyaluronic acid, stem cells could relieve OA symptoms significantly. No serious adverse effect was found.
Conclusion: There are significant therapeutic effects on joint function, symptoms, and no permanent adverse effect has been found after stem cell treatment. It is promising to apply intro-articular injection of stem cells for OA to clinical application. More researches are needed to supplement present deficiencies.
Keywords: Adverse effects; Mesenchymal stem cells; Osteoarthritis; Therapy.
Similar articles
-
Clinical therapeutic efficacy of mesenchymal stem cells derived from adipose or bone marrow for knee osteoarthritis: a meta-analysis of randomized controlled trials.J Comp Eff Res. 2020 Apr;9(5):361-374. doi: 10.2217/cer-2019-0187. Epub 2020 Mar 6. J Comp Eff Res. 2020. PMID: 32141308
-
Does the Source of Mesenchymal Stem Cell Have an Effect in the Management of Osteoarthritis of the Knee? Meta-Analysis of Randomized Controlled Trials.Cartilage. 2021 Dec;13(1_suppl):1532S-1547S. doi: 10.1177/1947603520951623. Epub 2020 Aug 25. Cartilage. 2021. PMID: 32840122 Free PMC article.
-
Autologous adipose stem cell therapy for knee osteoarthritis: where are we now?Phys Sportsmed. 2020 Nov;48(4):392-399. doi: 10.1080/00913847.2020.1758001. Epub 2020 Apr 27. Phys Sportsmed. 2020. PMID: 32312142
-
Effect of intra-knee injection of autologous adipose stem cells or mesenchymal vascular components on short-term outcomes in patients with knee osteoarthritis: an updated meta-analysis of randomized controlled trials.Arthritis Res Ther. 2023 Aug 10;25(1):147. doi: 10.1186/s13075-023-03134-3. Arthritis Res Ther. 2023. PMID: 37563715 Free PMC article. Review.
-
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).J Transl Med. 2016 Aug 26;14(1):246. doi: 10.1186/s12967-016-0998-2. J Transl Med. 2016. PMID: 27565858 Free PMC article. Clinical Trial.
Cited by
-
Co-Culture Approaches in Cartilage and Bone Tissue Regeneration.Int J Mol Sci. 2025 Jun 14;26(12):5711. doi: 10.3390/ijms26125711. Int J Mol Sci. 2025. PMID: 40565176 Free PMC article. Review.
-
The Effectiveness and Safety of Mesenchymal Stem Cells in the Treatment of Osteoarthritis: A Systematic Review and Meta-analysis of 28 Randomized Controlled Trials.Stem Cells Int. 2022 Oct 12;2022:6151866. doi: 10.1155/2022/6151866. eCollection 2022. Stem Cells Int. 2022. PMID: 36277037 Free PMC article.
-
How the mechanical microenvironment of stem cell growth affects their differentiation: a review.Stem Cell Res Ther. 2022 Aug 13;13(1):415. doi: 10.1186/s13287-022-03070-0. Stem Cell Res Ther. 2022. PMID: 35964140 Free PMC article. Review.
-
A systematic review, umbrella review, and quality assessment on clinical translation of stem cell therapy for knee osteoarthritis: Are we there yet?Stem Cell Res Ther. 2023 Apr 15;14(1):91. doi: 10.1186/s13287-023-03332-5. Stem Cell Res Ther. 2023. PMID: 37061744 Free PMC article.
-
Commercial Insurance Payer References Do Not Substantiate Coverage Denial of Stem Cell Therapy for Orthopedic Applications.HSS J. 2025 Aug 5:15563316251357013. doi: 10.1177/15563316251357013. Online ahead of print. HSS J. 2025. PMID: 40777848 Free PMC article. Review.
References
-
- Bijlsma JWJ, Berenbaum F, Lafeber FPJG (2011) Osteoarthritis: an update with relevance for clinical practice. Lancet 377(9783):2115–2126. https://doi.org/10.1016/S0140-6736(11)60243-2 - DOI - PubMed
-
- Lin J, Fransen M, Kang X, Li H, Ke Y, Wang Z, Zhang Y, Su S (2010) Marked disability and high use of nonsteroidal antiinflammatory drugs associated with knee osteoarthritis in rural China: a cross-sectional population-based survey. Arthr Res Ther 12(6):R225. https://doi.org/10.1186/ar3212 - DOI
-
- Strotman PK, Novicoff WM, Nelson SJ, Browne JA (2019) Increasing public interest in stem cell injections for osteoarthritis of the hip and knee: a google trends analysis. J Arthroplast 34(6):1053–1057. https://doi.org/10.1016/j.arth.2019.03.002 - DOI
-
- Reisbig NA, Pinnell E, Scheuerman L, Hussein H, Bertone AL (2019) Synovium extra cellular matrices seeded with transduced mesenchymal stem cells stimulate chondrocyte maturation in vitro and cartilage healing in clinically-induced rat-knee lesions in vivo. PLoS ONE 14(3):e0212664. https://doi.org/10.1371/journal.pone.0212664 - DOI - PubMed - PMC
-
- Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5):1076–1084 - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical